Doug Dahl provides technical knowledge and advice to companies on a wide range of federal tax and ERISA matters regarding employee benefits, including qualified retirement plans, executive compensation arrangements and health and welfare plans. Doug regularly assists companies with employee benefit issues that arise during and following various corporate transactions and events, such as mergers, acquisitions, dispositions and bankruptcies.
Drawing on his experience as an attorney with the IRS, Office of Chief Counsel and his involvement with employee benefits at a National level in Washington, D.C., Doug represents companies in various interactions with the IRS, the Department of Labor, and the Pension Benefit Guaranty Corporation (PBGC). Doug’s practice involves:
American Health Law Association (AHLA)
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Representation of King’s Daughters Health System in its joint venture partnership with UK HealthCare, the clinical health care system of the University of Kentucky, that will create new opportunities for both organizations to better serve patients throughout Kentucky, southern Ohio and West Virginia
Representation of Regent Surgical Health, an ambulatory surgery center management and development company, in its strategic investment from TowerBrook Capital Partners L.P., an international investment management firm, and Ascension Capital, an investment affiliate of Ascension.
Representation of Premise Health, the largest direct health care provider in the country and OMERS portfolio company, in its acquisition of Sonic Boom Wellness, a provider of corporate wellness technology
We represented Gibson, the iconic American instrument brand, in its acquisition of Mesa/Boogie, one of the most prestigious brands in sound and guitar amplification. Centered on decades of professional experience and a true passion for sound, this historical transaction perfectly aligned with Gibson’s efforts to renew the iconic brand’s legacy and commitment to musicians around the world. The partnership was a natural collaboration of iconic American brands on a mutual quest of sound, quality and craftsmanship and to push the boundaries of how guitar sound is delivered and experienced. In addition, Mesa/Boogie founder Randy Smith will join Gibson as Master Designer and Mesa/Boogie amps will be available in Gibson’s Custom Shop for Amplifiers.
Representation of Complete Health Partners, a Pharos Capital Group primary care platform based in Jacksonville, Florida, in its acquisitions of two Birmingham, AL primary care practices, Northside Medical Associates and Adamsville Family Medicine
Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its definitive agreement to acquire Queen City Hospice, LLC, and its affiliate Miracle City Hospice, LLC for a cash purchase price of $192.0 million
Representation of Premise Health, the country’s largest direct health care provider and OMERS Private Equity portfolio company, in its acquisition of CareHere, another leading operator of wellness centers for self-funded organizations. The acquisition of CareHere, brings Premise Health’s revenue to approximately $1 billion annually and increases its geographic footprint to more than 850 centers across 45 states and Guam. The combination will allow Premise Health to deliver improved outcomes and enhance health care for employer populations.
Representation of MSouth Equity Partners, a private equity firm with a focus on lower middle market management buyouts, in its acquisition of iBenefit Communication, a benefit communication, engagement, and enrollment services company
Representation of Scriptcycle in its $60 million cash sale to GoodRx Holdings, Inc. (Nasdaq: GDRX)
The Tax Lawyer — Senior Staff Mentor
American Journal of Trial Advocacy — Executive Editor